Background
Bioprinting technologies and their applications
Biomaterials | Cell viability/resolution | Bioprinting speed | Cost | Advantages | Disadvantages | References | |
---|---|---|---|---|---|---|---|
Inkjet-based bioprinting | Low-viscosity suspension of living cells; biomolecules; growth factors | ~90 % 20–100 µm | Fast (<10,000 droplets/s) | Low | Wide availability; low cost; high resolution; high printing speed; ability to introduce concentration gradients in 3D constructs | Poor vertical structure clogging characteristics; thermal and mechanical stress to cells; limited printable materials (liquid only) | |
Pressure-assisted bioprinting | Hydrogel; melt; cells; proteins and ceramic materials; solutions, pastes, or dispersions of low to high viscosity; PLGA; tricalcium phosphate (TCP); collagen and chitosan; collagen-alginate-silica composites coated with HA; and agarose with gelatin | 40–80 % 200 µm | Slow | Medium | Numerous materials that can be printed with any dimensions; mild conditions (room temperature); use of cellular spheroids; direct incorporation of cells; and homogenous distribution of cells | Limited mechanical stiffness; critical timing of gelation time; specific matching of the densities of the material and the liquid medium to preserve shapes; low resolution and viability | |
Laser-assisted bioprinting | Hydrogel, media, cells, proteins and ceramic materials of varying viscosity | >95 % >20 µm | Medium | High | Nozzle-free, noncontact process; cells are printed with high activity and high resolution; high control of ink droplets and precise delivery | High cost; cumbersome and time consuming; requires a metal film and thus is subject to metallic particle contamination | |
Stereolithography | Light-sensitive polymer materials; curable acrylics and epoxies | >90 % ~1.2–200 µm | Fast (<40,000 mm/s) | Low | Solid freeform and nozzle-free technology; highest fabrication accuracy; compatibility with an increasing number of materials; light-sensitive hydrogels can be printed layer-by-layer | Applicable to photopolymers only; lack of biocompatible and biodegradable polymers; harmful effects from residual toxic photo-curing reagents; possibility of harm to DNA and human skin by UV | [45] |
Inkjet-based bioprinting
Pressure-assisted bioprinting and its applications
Laser-assisted bioprinting
Stereolithography
Key points of bioprinting
Parameters of biomaterials
Biocompatibility
Porosity and interconnectivity
Mechanical properties
Bone type | Porosity (%) | Pore size (μm) | Compressive strength (MPa) | Young’s modulus (GPa) |
---|---|---|---|---|
Cortical bone | 3–12 | <500 | 130–225 | 3–30 |
Cancellous bone | 50–90 | 500–1000 | 4–12 | 0.01–0.5 |
Material | Porosity and compressive strength | Biological properties | Printing type | References |
---|---|---|---|---|
SiO2/ZnO | 32–52 % and 2–10 MPa | Increased mechanical strength and cellular proliferation | Inkjet-based bioprinting | [105] |
β-TCP/POC (poly-1,8-octanediol-co-citrate) | 45 % | High compressive modulus and good drug delivery performance | Micro-droplet jetting | [106] |
CaSiO3
| 70 % and 7 MPa | Enhanced cell attachment and osteogenic activity | 3D printing | [100] |
CaCO3/SiO2
| 34 % and 47 MPa | resulting in improved mechanical properties and good cell affinity | Laser-aided gelling (LAG) | [107] |
Sr–Mg doped TCP | 4–12 MPa | Increased osteons and, consequently, an enhanced network of blood vessel formation and osteocalcin expression | 3D printing | [108] |
HA/PVOH (poly(vinyl)alcohol) | 55 % and 0.88 MPa | Osteoconduction and osteointegration in vivo | 3D printing | [109] |
HSP bioceramic (hollow-struts-packed) | 65–85 % and ~5 MPa | Significantly improved cell attachment and proliferation; promotion of formation of new bone tissue in the center of the scaffolds | A modified coaxial 3D printing | [110] |
Classification and ink formulations
Bioprinting cells
Viability of post-printed cells
Bioprinting stem cells
Single-cell patterning
Extracellular microenvironment
Advanced applications of bioprinted tissues and organs
Bioprinted tissues and organs | 3D printing technology | Applications | Future directions | References |
---|---|---|---|---|
Blood vessels | Inkjet bioprinting | Optimizing vascular geometry and cell viability and function Predicting flow rates, oxygen tension, and the diffusion of molecules in the vascular environment | Improving resolution for printing small vessels Increasing available bioink materials Increasing bioprinting speed | |
Extrusion bioprinting | ||||
Laser-assisted bioprinting | ||||
Heart | Extrusion-based bioprinting | Printing valvular interstitial cells into scaffolds with high speed and good viability (~100 %) over 21 days Printing hydrogel-based valve-shaped structures | Developing types of materials with good flexibility and elasticity | |
FRESH | ||||
Bone | SLA | Printing scaffolds that provide a framework for cells to attach, proliferate and function and to be integrated with the surrounding tissue Accurately controlling pore geometry, cell viability and mechanical properties | Investigating printed materials with osteoinductive or osteoconductive proteins Triggering vascularization in the repaired region | |
Laser-assisted bioprinting | ||||
Liver | Inkjet printing | Printing biological livers for liver transplantation in patients with liver resection Constructing artificial liver tissue for the detection of drug toxicities and other medical and biological testing | Constructing 3D functional liver tissue with a substantial capillary-like network | |
Skin | Inkjet bioprinting | Fabricating skin substitutes to repair skin wounds Studying the pathophysiology of skin diseases | Fabricating more complex human skin models with secondary and adnexal structures Improving LAB technology to achieve automation for bioprinting skin | |
Extrusion bioprinting | ||||
Laser-assisted bioprinting |